I first learned of the possibility of there being a comparative study of Avastin vs. Lucentis in June 2007. I then followed its progress until it finally became a reality in February 2008. The eighth installment traces how it became a reality in the author's own words.
According to an official with the CATT Study, it is on track and proceeding well. The 44 participating centers have recruited over 850 of the called-for 1200 enrollments and anticipate completing patient enrollment by the end of the year.
One-year results from the study are expected to be released in early 2011.
The study began enrolling patients in February 2008.